We say “needle exchange,” but open access—not one-for-one exchange—is best for health
Syringe access programs combat the spread of infectious diseases among people who use injection drugs, improve participant health, and increase linkage to social services including drug treatment.
CROI 2018: A roundup of the most exciting PrEP news & research
Liz Highleyman summarizes the PrEP and HIV prevention research presented recently at the domestic HIV conference, CROI, including a new possible PrEP drug, real world PrEP effectiveness, and more.
Dr. Kenneth Mayer discusses the state of PrEP uptake and delivery in the U.S., with an eye toward reducing barriers for people who may benefit from this method of HIV prevention.
Here’s what you need to know about HIV drug resistance
Here’s a low-down on HIV drug resistance, including what it is and how you get tested for it. Also, get advice from HIV clinicians on prevention and what to do if you do develop HIV drug resistance.
Are serious heart problems inevitable for people with HIV? A conversation with cardiologist Priscilla Hsue
Cardiologist Priscilla Hsue answered questions about inflammation and cardiovascular disease among people living with HIV at a recent Positive Force event.
Raw sex: What the research says about risk when you’re undetectable
Read why one man living with HIV doesn’t use condoms with his HIV-negative partner—and about research showing that risk of transmitting HIV is minimal.
PrEP researcher Dr. Robert Grant and PrEP Fact founder Damon Jacobs weigh in about what this case of HIV infection while on PrEP means for members of our community.
